AC
TMO icon

Apella Capital’s Thermo Fisher Scientific TMO Stock Holding History

Apella Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656K Sell
1,269
-23
-2% -$11K 0.01% 425
2026
Q1 		$680K Buy
1,292
+548
+74% +$297K 0.01% 411
2025
Q4 		$431K Buy
744
+18
+2% +$10.2K 0.01% 385
2025
Q3 		$390K Buy
726
+86
+13% +$40K 0.01% 363
2025
Q2 		$268K Buy
640
+40
+7% +$16.7K 0.01% 369
2025
Q1 		$272K Buy
600
+57
+10% +$30.9K 0.01% 321
2024
Q4 		$282K Buy
543
+5
+0.9% +$2.75K 0.01% 292
2024
Q3 		$330K Buy
538
+42
+8% +$24.9K 0.01% 261
2024
Q2 		$264K Sell
496
-1
-0.2% -$573 0.01% 273
2024
Q1 		$293K Buy
497
+3
+0.6% +$1.68K 0.01% 247
2023
Q4 		$265K Hold
494
– – 0.01% 250
2023
Q3 		$250K Buy
494
+1
+0.2% +$533 0.02% 236
2023
Q2 		$257K Buy
+493
New +$266K 0.02% 229
2022
Q4 		$249K Buy
453
+20
+5% +$10.6K 0.02% 207
2022
Q3 		$220K Buy
433
+29
+7% +$16.2K 0.03% 196
2022
Q2 		$219K Buy
404
+45
+13% +$24.8K 0.03% 206
2022
Q1 		$212K Buy
+359
New +$206K 0.03% 197

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Apella Capital's TMO Position: Q2 2026 in Review

Apella Capital reduced its Thermo Fisher Scientific (TMO) stake by 1.8% in Q2 2026, selling an estimated $11K and leaving 1,269 shares worth $656K. The position accounts for 0.01% of the portfolio, ranked #425.

Apella Capital first reported a position in TMO in Q1 2022 and has held it in 17 quarters since. The position peaked at $680K in Q1 2026. 500 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Apella Capital held 1,269 shares of Thermo Fisher Scientific worth $656K as of Q2 2026.
  • Apella Capital sold 23 Thermo Fisher Scientific shares in Q2 2026, an estimated $11K.
  • Thermo Fisher Scientific made up 0.01% of Apella Capital's portfolio in Q2 2026, its #425 holding.
  • Apella Capital first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 17 quarters since.
  • Apella Capital's Thermo Fisher Scientific position peaked at $680K in Q1 2026.
  • 500 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.